Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier, Ari J Green, Orhan Aktas, Hans-Peter Hartung, Dewei She, William Rees, Michael Smith, Daniel Cimbora, Eliezer Katz, Jeffrey L Bennett
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
The Lancet. Neurology
extremes values regular variation point processes readable efficient account fundamental mathematical stochastic process techniques needed study behavior extreme val